Lower Your Non-HDL Cholesterol Naturally For Better Long-Term Health

🎧 ▶️ Press play below to listen in English.

🎧 Spanish Audio Introduction (Introducción en español)

Bienvenidos. Hoy hablaremos sobre el colesterol no-HDL, un marcador mucho más importante que el LDL para predecir riesgo cardíaco. Explicaremos qué significa, por qué es tan poderoso para evaluar la salud de tus arterias y qué hábitos pueden ayudarte a bajarlo de manera natural. Si buscas una guía clara y práctica para proteger tu corazón, este episodio es para ti.

🎧 Chinese Audio Introduction (中文音频简介 — 普通话)

“欢迎收听。本次内容将介绍非高密度胆固醇，也就是 non-HDL 胆固醇。它比传统的 LDL 更能评估心脏和血管的真实风险。我们会说明它的意义、为什么这么关键，以及日常生活中如何自然降低它的水平。如果你想更好地保护心血管健康，这段音频将对你非常有帮助。”

Introduction

Most people know their total cholesterol, LDL, and HDL numbers. But few know about a metric that many cardiologists today consider more powerful than LDL for predicting heart attacks and strokes: non-HDL cholesterol.

This single number gives a clearer picture of all the cholesterol-carrying particles that can enter your artery wall and form plaque. It is easy to calculate, requires no extra testing, and has been shown in major studies to be a superior predictor of cardiovascular disease—even in people with normal LDL.

This deep-dive explains what non-HDL cholesterol means, why it matters more than LDL in many cases, what optimal targets look like, and the most effective ways to lower it through lifestyle and evidence-based strategies.

---

I. What Is Non-HDL Cholesterol?

Non-HDL cholesterol is all the cholesterol in your blood that can contribute to plaque formation, except HDL (“good cholesterol”).

The calculation is simple:

Non-HDL Cholesterol = Total Cholesterol – HDL Cholesterol

Why is this important?

Because non-HDL represents all atherogenic (plaque-forming) particles, including:

• LDL (low-density lipoprotein)
• VLDL (very-low-density lipoprotein)
• IDL (intermediate-density lipoprotein)
• Chylomicron remnants
• Lipoprotein(a)

Every one of these particles can enter the arterial wall, trigger inflammation, and promote plaque buildup.

Why LDL Alone Isn’t Enough

LDL measures only one category of harmful particles. But atherosclerosis is driven by the total burden of atherogenic particles, not by LDL alone.

Someone may have:

• Low LDL
• But high VLDL, IDL, or Lp(a)

…and still be at high risk.

Non-HDL captures everything that matters.

---

II. Why Non-HDL Cholesterol Is a Better Predictor of Disease

Studies repeatedly show that non-HDL cholesterol is more predictive of:

• Heart attacks
• Ischemic strokes
• Peripheral arterial disease
• Cardiovascular death

Large meta-analyses have shown:

• Non-HDL correlates better with atherosclerotic plaque burden than LDL
• Non-HDL predicts residual risk even when LDL is at goal
• Non-HDL remains accurate in people with high triglycerides, where LDL becomes less reliable

And importantly: you don’t need to be fasting to measure it.

Why triglycerides matter

Triglycerides and atherogenic cholesterol travel together inside lipoprotein particles. When triglycerides rise, your body produces more VLDL particles—which raise non-HDL cholesterol.

This is why prediabetes, insulin resistance, and visceral fat often cause elevated non-HDL even when LDL seems normal.

---

III. What Your Non-HDL Cholesterol Levels Mean

What Targets Should You Aim For?

Non-HDL cholesterol targets differ slightly across major cardiology organizations, but all agree on one thing:

Non-HDL cholesterol is a powerful predictor of cardiovascular risk, and lower is better—especially if you have metabolic disease.

Below is a clear breakdown of what each guideline recommends, followed by practical advice on what readers should aim for.

---

1. American College of Cardiology / American Heart Association (ACC/AHA)

Guideline: 2018 and 2019 cholesterol/primary prevention guidelines
Recommended Non-HDL Targets:

• <130 mg/dL for general prevention
• <100 mg/dL for people with diabetes or multiple risk factors
• <80 mg/dL for very high-risk patients (established ASCVD or strong family history)

Notes:
ACC/AHA treats non-HDL as a secondary target but emphasizes its importance when triglycerides are high.

---

2. National Lipid Association (NLA)

Guideline: 2022 NLA Scientific Statement
Recommended Non-HDL Targets:
The NLA puts non-HDL as the primary target, above LDL-C.

• <130 mg/dL for low to moderate risk
• <100 mg/dL for high risk
• <80 mg/dL for very high risk

Notes:
The NLA strongly supports non-HDL because it captures all atherogenic particles, including remnants and Lp(a).

---

3. European Society of Cardiology (ESC/EAS)

Guideline: 2019 Dyslipidemia Guidelines
Recommended Non-HDL Targets (converted from LDL goals):

• <130 mg/dL → corresponds to LDL <100
• <100 mg/dL → corresponds to LDL <70
• <85 mg/dL → corresponds to LDL <55 (very high risk)

Notes:
Europe uses some of the lowest LDL and non-HDL targets in the world, especially for people with established heart disease.

---

4. Canadian Cardiovascular Society (CCS)

Guideline: 2021 CCS Dyslipidemia Guideline
Recommended Non-HDL Targets:

• <130 mg/dL for moderate risk
• <100 mg/dL for high risk
• <85 mg/dL for very high risk

Canada aligns closely with ESC/EAS in using more aggressive targets.

---

5. International Diabetes Federation (IDF)

Recommended Non-HDL Target for People with Diabetes:

• <100 mg/dL
• <80 mg/dL if additional risk factors are present

Notes:
Non-HDL is more reliable than LDL in people with diabetes because elevated triglycerides and remnants distort LDL measurements.

---

So What Should People Actually Strive For?

It depends on their metabolic and cardiovascular risk profile. Here’s the practical version:

---

If You Are Generally Healthy With No Major Risk Factors

Goal:
👉 Non-HDL < 130 mg/dL

This is acceptable for the average person without diabetes, hypertension, or obesity.

---

If You Have Prediabetes, Metabolic Syndrome, Hypertension, or a Strong Family History

Goal:
👉 Non-HDL < 100 mg/dL

This is the category your audience often falls into.

This level lowers lifetime ASCVD risk even if LDL is “normal.”

---

If You Have Diabetes or Significant Insulin Resistance

Goal:
👉 Non-HDL < 100 mg/dL (good)
👉 < 80 mg/dL (ideal)

The evidence shows that tight control here significantly reduces:

• Remnant cholesterol
• Small dense LDL
• Atherogenic VLDL particles
• Postprandial lipemia

---

If You Already Have Heart Disease or Very High Risk

Meaning:

• Prior heart attack
• Coronary calcification
• Stroke
• Known atherosclerosis
• Multiple risk factors

Goal:
👉 Non-HDL < 80 mg/dL (ACC/AHA)
👉 < 85 mg/dL (ESC/EAS)
👉 < 80 mg/dL (NLA)

This is the “aggressive prevention” category.

---

Bottom Line Summary

Most people should aim for a non-HDL cholesterol below 130 mg/dL.
If you have any metabolic issues—prediabetes, high triglycerides, or visceral fat—aim for below 100 mg/dL.
If you have established heart disease or diabetes, a target of 80 mg/dL or lower offers the greatest long-term protection.

---

IV. How Non-HDL Cholesterol Causes Atherosclerosis

Non-HDL particles damage arteries through:

1. Penetration Into the Artery Wall

These particles are small enough to enter the endothelium and lodge inside.

2. Oxidation

Once trapped, they oxidize—especially in people with:

• Hyperglycemia
• Chronic inflammation
• Smoking exposure
• Metabolic syndrome

3. Immune Activation

Oxidized lipoproteins trigger:

• Foam cell formation
• Smooth muscle migration
• Arterial wall thickening

4. Plaque Formation

Over decades, plaque becomes:

• Calcified
• Fibrotic
• Vulnerable to rupture

This progression happens even when LDL is normal—which is why non-HDL is such critical information.

---

V. Causes of High Non-HDL Cholesterol

1. Insulin Resistance

The #1 driver.

Insulin resistance increases:

• VLDL overproduction
• Triglyceride-rich particles
• Remnant cholesterol

All of these raise non-HDL.

2. Excess Sugar and Refined Carbohydrates

Sugary drinks, bread, pastries, pasta, and desserts rapidly raise triglycerides → more VLDL → higher non-HDL.

3. Visceral Fat

The more abdominal fat you store, the more triglyceride-rich particles your liver generates.

4. Low HDL

Low HDL increases non-HDL simply by math, but also reflects underlying metabolic dysfunction.

5. Poor Sleep and Chronic Stress

Both raise cortisol → increases VLDL output.

6. Alcohol

Even moderate alcohol in susceptible individuals boosts triglycerides and non-HDL.

7. Hypothyroidism

Low thyroid function slows LDL clearance, raising non-HDL.

---

VI. How to Lower Your Non-HDL Cholesterol Naturally

Below are evidence-based, high-impact strategies—aligned with your website’s Pareto principle theme.

1. Lower Postprandial Blood Sugar (Your Most Important Lever)

Hyperglycemia increases formation of:

• Small dense LDL
• Triglyceride-rich remnants
• Oxidized lipoproteins

Strategies:

• Walk 10–15 minutes after meals
• Reduce refined carbs
• Add viscous fibers (chia, flaxseed, okra, glucomannan)
• Prioritize protein and fats before carbs (“food order” strategy)
• Avoid sugary coffee drinks in the morning (tie to your future article)

2. Lose Visceral Fat

Even a 5% weight loss significantly lowers non-HDL.

Key tactics:

• Eat earlier in the day (your PPHG and breakfast articles support this)
• Reduce evening eating
• Emphasize resistance training
• High-intensity intervals 1–2×/week
• Train in the morning (aligned with your routine)

3. Increase Soluble and Viscous Fibers

The strongest natural methods:

• Flaxseed (connect to your article)
• Psyllium
• Oats
• Beans
• Okra
• Eggplant
• Nuts

Soluble fiber reduces cholesterol absorption and improves insulin sensitivity.

4. Build Muscle

Muscle is the largest glucose sink in the body.

More muscle → better insulin response → lower triglycerides → lower non-HDL.

Your kettlebell + bodyweight training is perfect for this.

5. Improve Sleep

Poor sleep elevates:

• Triglycerides
• Cortisol
• Appetite hormones

Aim for 7–9 hours, consistent schedule.

6. Reduce or Eliminate Alcohol

Alcohol raises triglycerides sharply.

Even two drinks can spike non-HDL in susceptible individuals.

7. Consider Omega 3 Fatty Acids (EPA/DHA)

Fish oil lowers triglycerides, reducing VLDL and non-HDL.

Best evidence is for:

• 2–4 g/day EPA/DHA
• Or prescription EPA (icosapent ethyl)

---

VII. What to Ask Your Doctor

If your non-HDL is elevated, bring these points up:

1. Is my high non-HDL due to insulin resistance?

Very often, yes. Insulin resistance is one of the most common reasons people develop elevated non-HDL cholesterol—especially when triglycerides are high, HDL is low, or there is excess abdominal fat. When the body becomes resistant to insulin, the liver produces more VLDL (a triglyceride-rich, atherogenic particle), which directly raises non-HDL cholesterol.

While fasting insulin and HOMA-IR are the best tests for detecting early insulin resistance, they are rarely ordered in routine clinical practice. Most primary care physicians rely instead on more commonly available markers that indirectly reveal the same problem.

You can ask your doctor to look at these practical indicators:

• Triglyceride-to-HDL ratio
  A ratio > 2.5 in mg/dL units strongly suggests insulin resistance.
• Fasting triglycerides
  Levels ≥150 mg/dL are often a sign of impaired metabolic health.
• A1C and fasting glucose
  Even “high normal” values can indicate early insulin resistance.
• Blood pressure trends
  Hypertension frequently travels with insulin resistance.
• Waist circumference
  Increased abdominal fat almost always means worsening insulin sensitivity.

Waist Circumference: What Numbers Signal Insulin Resistance?

Waist size is one of the simplest and most reliable indicators of metabolic health. Unlike BMI, waist circumference directly reflects visceral fat, the deep abdominal fat strongly linked with insulin resistance, high triglycerides, fatty liver, and elevated non-HDL cholesterol.

Different ethnicities have different cutoffs because visceral fat distribution varies between populations.

White / European Cutoffs

Men:

• ≤ 40 inches (102 cm) — acceptable
• > 40 inches — high visceral fat, likely insulin resistance

Women:

• ≤ 35 inches (88 cm) — acceptable
• > 35 inches — high visceral fat, likely insulin resistance

Asian Cutoffs (More Strict)

Asians accumulate visceral fat at lower waist sizes, which means risk begins earlier.

Men:

• ≤ 35.4 inches (90 cm) — acceptable
• > 90 cm — high metabolic risk

Women:

• ≤ 31.5 inches (80 cm) — acceptable
• > 80 cm — high metabolic risk

Why waist size matters

A larger waistline almost always indicates:

• Increased visceral fat
• Worsened insulin sensitivity
• Higher triglyceride production
• Higher VLDL output
• Higher non-HDL cholesterol

Even if weight or BMI seems “normal,” a high waist circumference is enough to suspect insulin resistance—especially in Asians and South Asians, who are metabolically vulnerable at lower body weights.

If your doctor is open to ordering fasting insulin or HOMA-IR, they can provide a much earlier and clearer picture—but it’s important to acknowledge that most clinics do not routinely check them.

Bottom line

You don’t necessarily need advanced tests to uncover insulin resistance.
If your triglycerides are elevated, HDL is low, or your waistline has increased, there’s a good chance insulin resistance is contributing to your high non-HDL cholesterol.

And the good news is that improving insulin sensitivity—through muscle-building exercise, lowering postprandial glucose, and reducing refined carbs—almost always improves non-HDL as well.

2. Should I measure ApoB?

For most people, the answer is yes—ApoB is worth measuring. If you want the most accurate picture of your cardiovascular risk, ApoB provides information that even non-HDL cholesterol cannot fully capture.

ApoB directly counts the number of atherogenic particles circulating in your blood. Each LDL, VLDL, IDL, and Lp(a) particle carries exactly one ApoB molecule. That means ApoB is essentially a particle counter—and the number of particles matters more than the amount of cholesterol inside them. Smaller particles carry less cholesterol, but they are more numerous and more likely to enter the artery wall. LDL-C can look “normal” while ApoB is high, which means risk is still high.

You should especially measure ApoB if:

• You have metabolic syndrome, prediabetes, or insulin resistance
• Your triglycerides are elevated
• You have a family history of early heart disease
• You’ve been told your LDL is “normal” but your non-HDL is high
• You want a more precise measurement to guide your prevention plan

ApoB testing is inexpensive, widely available, requires no special preparation, and is now recommended by many cardiology societies as a superior risk marker compared to LDL alone.

If your goal is to prevent heart disease—not just treat high cholesterol—then measuring ApoB gives you the clearest, most actionable insight into your real particle burden and your true risk.

3. Could hypothyroidism be contributing?

Yes. Even mild (subclinical) hypothyroidism can raise your non-HDL cholesterol. Thyroid hormones help regulate how quickly your body clears LDL, VLDL, and other atherogenic particles from the bloodstream. When thyroid function is low, the liver produces fewer LDL receptors, slowing the removal of these particles. This leads to:

• Higher LDL
• Higher VLDL and remnant particles
• Higher non-HDL cholesterol
• Higher triglycerides
• Sluggish metabolism and weight gain that further worsen cholesterol levels

Because of this strong connection, unrecognized hypothyroidism is one of the most common reversible causes of high non-HDL cholesterol.

To evaluate thyroid function properly, you should ask your doctor for:

• TSH (thyroid-stimulating hormone)
  High TSH often indicates that the thyroid is working too hard to maintain hormone levels.
• Free T4
  Shows the actual circulating level of thyroxine.
• Free T3 (optional but helpful in some cases)
  Indicates whether your body is converting T4 to its active form.
• Thyroid peroxidase (TPO) antibodies)
  Helps identify autoimmune thyroid disease (Hashimoto’s), which is a frequent cause of mild hypothyroidism.

If thyroid issues are found and treated, cholesterol numbers—including non-HDL—often improve significantly within a few months without any additional medication.

4. Should I repeat my lipid panel fasting?

Non-HDL doesn’t require fasting—but triglycerides may be more accurate if repeated fasting.

5. Should I check my Lipoprotein(a) level?

Yes—Lp(a) testing is essential, and it fits perfectly into the discussion about non-HDL cholesterol.
Even though Lp(a) is technically included within your non-HDL value (because it carries cholesterol), non-HDL cannot tell you whether your Lp(a) is elevated. People can have:

• Normal LDL
• Normal non-HDL
• But very high Lp(a)

…and still be at significantly higher risk for heart disease, aortic valve stenosis, and stroke.

Why?
Because Lp(a) is not dangerous for the cholesterol it carries—it is dangerous because of its structure, which makes it:

• Highly inflammatory
• Highly prone to forming clots
• Highly atherogenic even at modest levels

Lp(a) is genetically determined, stable throughout life, and usually measured only once.

Who should test for Lp(a)?

Ask your doctor for an Lp(a) test if:

• You have a family history of early heart disease
• Your LDL or non-HDL seems “too high for no reason”
• You have had a heart attack despite “normal” cholesterol
• You have calcification in your arteries despite healthy lifestyle habits
• A relative tested positive for high Lp(a)

How Lp(a) fits into non-HDL cholesterol

Non-HDL cholesterol includes Lp(a), but:

• Non-HDL cannot quantify it
• High Lp(a) requires different management strategies
• Statins do not lower Lp(a) (they may slightly increase it)

This is why knowing your Lp(a) number is crucial.
If it’s elevated, you may need:

• Aspirin (select cases, doctor-supervised)
• PCSK9 inhibitors
• Niacin (limited use, case-by-case)
• Aggressive control of ApoB and non-HDL
• Lifestyle strategies to reduce inflammation

Bottom line

Yes—ask your doctor to check your Lp(a).
Even though it is part of non-HDL, it behaves differently, carries unique risks, and requires separate attention. Linking this with your recently published Lp(a) article gives readers a complete and actionable heart-risk assessment.

---

VIII. When to Consider Medication

For high-risk individuals, lifestyle and medications can be combined.

You may consider add-on therapy if:

• Non-HDL ≥ 160 mg/dL
• Persistent non-HDL above goal despite lifestyle changes
• Strong family history or high Lp(a)

Therapies that reduce non-HDL include:

• Statins (lower LDL and reduce VLDL production)
• Ezetimibe
• PCSK9 inhibitors (especially if Lp(a) is high)
• Fibrates (for triglycerides)
• Prescription EPA

But for many patients, lifestyle alone is enough, especially if insulin resistance is the main driver.

Conclusion

Non-HDL cholesterol is one of the most powerful yet overlooked markers for understanding your true cardiovascular risk. Unlike LDL alone, it captures all the harmful particles that drive plaque formation—VLDL, IDL, remnants, and lipoprotein(a). That means it gives you a more complete picture of what is happening inside your arteries, especially if you have prediabetes, insulin resistance, high triglycerides, or visceral fat.

The good news is that non-HDL cholesterol responds quickly to practical changes. Improving postprandial blood sugar, building muscle, reducing refined carbs, adding viscous fibers, improving sleep, and limiting alcohol can create measurable improvements within weeks. These same strategies also support better metabolic health, healthier arteries, and longer life.

Whether you are just starting your health journey or refining an existing plan, tracking your non-HDL cholesterol is one of the smartest steps you can take. Understanding the number—and taking daily actions to lower it—gives you real control over your cardiovascular future.

---

FAQs About Non-HDL Cholesterol

Don’t Get Sick!

Medically Reviewed by Dr. Jesse Santiano, MD
Dr. Santiano is a retired internist and emergency physician with extensive clinical experience in metabolic health, cardiovascular prevention, and lifestyle medicine. He reviews all medical content on this site to ensure accuracy, clarity, and safe application for readers. This article is for educational purposes and is not a substitute for personal medical care.

Medical Disclaimer

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Do not change or stop any medications, diet, or exercise program based on this information without first consulting your physician or qualified health provider.

If you have questions about your medical condition, always seek the advice of your healthcare professional. If you think you may be experiencing a medical emergency, call your doctor or local emergency services immediately.

Content Disclaimer

All information on this website reflects the author’s interpretation of current scientific literature, clinical experience, and expert guidelines at the time of writing. While every effort is made to ensure accuracy, medical knowledge evolves, and recommendations may change.

This article does not claim to diagnose, cure, or prevent any disease. Readers are encouraged to review the references provided and to consult their healthcare team for personalized guidance.

💡 Support This Work

Creating well-researched articles, maintaining this website, and keeping the information free takes time and resources.
If you found this article helpful, please consider donating to support the mission of empowering people to live healthier, longer lives, without relying on medications.

🙏 Every contribution, big or small, truly makes a difference. Thank you for your support!

Follow me on Facebook, Gab, Twitter (formerly known as X), and Telegram.

Related:

1. Conquer Sugar Spikes With A Simple Morning Green Tea Ritual
2. Antioxidants And Timing: How To Reduce Blood Sugar-Related Oxidative Stress
3. Health Benefits of Alpha Lipoic Acid: The Excellent Antioxidant
4. Flaxseed: Lowers Sugar And Awesome Source of Valuable Omega 3
5. 11 Best Morning Supplements For Energy
6. Mastering Diabetes: Prevent Hypoglycemia with Smart Medication Adjustments
7. 102 Easy Ways to Lower Post-Prandial Blood Sugar Without Meds
8. The Simple Way To Keep Blood Sugar Low: Breakfast
9. Meal Timing: A Practical Guide To Weight Loss And Better Health
10. 18 Powerful Strategies To Prevent Blood Sugar Spikes During The Holidays
11. Applying The Best Behavior Change Techniques At Home For Better Health
12. A Toolbox of Strategies to Prevent Blood Sugar Spikes When Eating High-Glycemic- Index Foods
13. The Blood Sugar Lowering and Metabolic Effects of Vinegar
14. Ways to Lower After-Meal Blood Sugar when Eating White Bread
15. A High-Protein Breakfast Can Lower Blood Sugar the Whole Day
16. Eating rather than skipping breakfast results in lower blood sugars the whole day
17. Pistachios improve insulin resistance and inflammatory markers
18. Pistachios decrease after-meal blood sugar
19. Veggies Meat Carbohydrate Sequence Prevents After Meal Sugar Spike
20. Passing and Failing the One-Hour After-Meal Blood Sugar
21. Low One-Hour Post-Prandial Blood Sugar after One Cup of Rice

References:

1. Wright JD, Folsom AR, Coresh J, Sharrett AR, Couper D, Wagenknecht LE, Mosley TH Jr, Ballantyne CM, Boerwinkle EA, Rosamond WD, Heiss G. The ARIC (Atherosclerosis Risk In Communities) Study: JACC Focus Seminar 3/8. J Am Coll Cardiol. 2021 Jun 15;77(23):2939-2959. doi: 10.1016/j.jacc.2021.04.035. PMID: 34112321; PMCID: PMC8667593. https://pmc.ncbi.nlm.nih.gov/articles/PMC8667593/
2. Messersmith A, Purbey R, Tannock LR. Risk of Fasting and Non-Fasting Hypertriglyceridemia in Coronary Vascular Disease and Pancreatitis. [Updated 2025 Jun 3]. In: Feingold KR, Ahmed SF, Anawalt B, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK513129/ https://www.ncbi.nlm.nih.gov/books/NBK513129/
3. Carr SS, Hooper AJ, Sullivan DR, Burnett JR. Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment. Pathology. 2019 Feb;51(2):148-154. doi: 10.1016/j.pathol.2018.11.006. Epub 2018 Dec 27. PMID: 30595507. https://pubmed.ncbi.nlm.nih.gov/30595507/
4. Arnett DK, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Sep 10;140(11):e596-e646. doi: 10.1161/CIR.0000000000000678. Epub 2019 Mar 17. PMID: 30879355; PMCID: PMC7734661. https://pubmed.ncbi.nlm.nih.gov/30879355/
5. François M et al. ESC Scientific Document Group , 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS), European Heart Journal, Volume 41, Issue 1, 1 January 2020, Pages 111–188, https://doi.org/10.1093/eurheartj/ehz455
6. Anne L. Peters; Clinical Relevance of Non-HDL Cholesterol in Patients With Diabetes. Clin Diabetes 1 January 2008; 26 (1): 3–7. https://doi.org/10.2337/diaclin.26.1.3
7. Pearson GJ, et al. 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults. Can J Cardiol. 2021 Aug;37(8):1129-1150. doi: 10.1016/j.cjca.2021.03.016. Epub 2021 Mar 26. PMID: 33781847. https://pubmed.ncbi.nlm.nih.gov/33781847/
8. IDF Clinical Practice Recommendations for managing Type 2 Diabetes in Primary Care. chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://idf.org/media/uploads/2023/05/attachments-63.pdf

Disclaimer:
This article is for educational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician before making health decisions based on the TyG Index or other biomarkers.

© 2018 – 2025 Asclepiades Medicine, LLC. All Rights Reserved
DrJesseSantiano.com does not provide medical advice, diagnosis, or treatment

As an Amazon Associate, I earn from qualifying purchases